订阅小程序
旧版功能

38MO Progression-free Survival (PFS) in Primary Advanced or Recurrent Endometrial Cancer (pa/rec) in the Overall and Mismatch Repair Proficient (MMR/MSS) Populations and in Histological and Molecular Subgroups: Results from Part 2 of the RUBY Trial

ESMO Open(2024)

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要